Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
03/2002
03/14/2002WO2002020014A1 Incompetitive inhibitors of helicase primase
03/14/2002WO2001085760A8 Thrombin inhibitors
03/14/2002WO2001072290A3 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
03/14/2002US20020032346 Production of mixed acid anhydride and amide compound
03/14/2002US20020032227 Oxime derivative and bactericide containing the same as active ingredient
03/14/2002US20020032225 Treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis.
03/14/2002US20020032222 Azolidines as beta-3 adrenergic receptor agonists
03/14/2002US20020032189 Amine compounds, their production and use
03/14/2002US20020032186 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
03/14/2002CA2421506A1 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
03/13/2002EP1186606A1 Epothilone derivatives, their preparation and utilization
03/13/2002EP1186594A1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
03/13/2002EP1186588A1 6-hydroxy-2-naphthylcarbinol and process for the preparation thereof
03/13/2002EP1186318A2 Combination, for treating depression and anxiety, containing a 5HT1d receptor antagonist and aCNS penetrant NK-1 receptor antagonist
03/13/2002EP1185521A1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors
03/13/2002EP1185520A1 Method for the production of thiazolidin
03/13/2002EP1185261A1 Il-8 receptor antagonists
03/13/2002EP0858452B1 Thiazole derivative as protein kinase c inhibitors
03/13/2002EP0802910B1 Estrogen agonists/antagonists
03/13/2002CN1340049A 4-heterocyclylsulfonamide)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl-or-pyridylpyrimidines as endothelin receptor antagonists
03/13/2002CN1080720C 噻唑衍生物 Thiazole derivatives
03/12/2002US6355806 Regulators of cell proliferation and differentiation, agents for treating skin-related diseases
03/12/2002US6355805 β3-adrenergic receptor agonists
03/12/2002US6355673 Substituted diaminocarboxylic acids
03/12/2002US6355672 Bone disorders; central nervous system disorders
03/12/2002US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents
03/12/2002US6355441 Benzothiazole dioxetanes
03/07/2002WO2002018365A1 N-heteroarylmethyl-p-phenylendiamine derivatives and compounds containing oxidation colouring agents
03/07/2002WO2002018333A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
03/07/2002WO2002018321A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
03/07/2002WO2002017915A1 Benzylidene thiazolidinediones and their use as antimycotic agents
03/07/2002WO2002017712A2 Disubstituted benzenes as insecticides
03/07/2002WO2001093802A3 Use of riluzole or its salts for preventing and treating adrenoleukodystrophy
03/07/2002WO2001068645A3 N-cyanomethylcarboxamides and their use as protease inhibitors
03/07/2002US20020028975 Process for preparing retiferol derivatives
03/07/2002US20020028950 Guanidinylamino heterocycle compunds useful as alpha-2 adrenoceptor agonists
03/07/2002US20020028946 Process for the preparation of heteroaryl-phenylalanines
03/07/2002US20020028818 2-nitrostyryl-1-(naphthylmethyl)sulfone for example
03/07/2002US20020028809 Heterocyclic compounds having effect of activating a4beta2 nicotinic acetylcholine receptors
03/07/2002US20020028806 As a pour-on or spot-on on formulation for controlling parasites such as fleas in warm blooded animals; such as 2,2-dimethylbutyric acid, (1-((6-chloro-pyridin-3-ylmethyl)-ethyl-amino)-2-nitrovinyl)-methyl -carbamoyloxy)-methyl ester
03/07/2002CA2420969A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
03/06/2002EP1183247A1 Polycyclic thiazole systems and their utilization as anorectics
03/06/2002EP1183245A1 Selective npy (y5) antagonists
03/06/2002EP1183237A1 Novel antioxidants, preparation methods and uses
03/06/2002EP1183233A2 Bradykinin receptor antagonists
03/06/2002EP1183229A1 Glucagon antagonists/inverse agonists
03/06/2002EP1183019A2 Ace-2 inhibiting compounds and methods of use thereof
03/06/2002CN1338452A Substituted phenylamine derivatives
03/06/2002CN1080257C Guanidine derivatives
03/06/2002CA2356797A1 Combination treatment for depression and anxiety
03/05/2002US6353111 Which increase insulin secretion in the treatment of type ii diabetes; 2,3-di-substituted trans olefinic n-heteroaromatic or urido propionamides: the substitution at the 2-position being a substituted phenyl group and at the 3-position a
03/05/2002US6353011 Drugs for endocrines and cardiovascular disorders
03/05/2002US6352993 Pyrimidine derivatives and processes for the preparation thereof
03/05/2002US6352987 Anorectic and antidiabetic agents
03/05/2002CA2206122C Arylacrylamide derivatives
02/2002
02/28/2002WO2002016335A2 Catalytic process for the preparation of thiazole derivatives
02/28/2002WO2002016334A1 Continuous process for the preparation of pesticidal chlorothiazoles
02/28/2002WO2002016333A2 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease
02/28/2002WO2002016327A1 Benzimidazoles and analogues and their use as neutrophil inhibitors
02/28/2002WO2002016319A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
02/28/2002WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
02/28/2002WO2002016316A1 10-ARYL-11-HBENZO [b]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE
02/28/2002WO2001076390A3 Flavouring a foodstuff with compounds containing a sulfur atom linked to two specific atoms or groups
02/28/2002US20020026060 RAR selective retinoid agonists
02/28/2002US20020025976 Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use
02/28/2002US20020025975 Antidiabetic agents; antiinflammatory agents
02/28/2002US20020025910 3-heterocycly1 - substituted benzoyl derivatives
02/28/2002CA2420289A1 10-aryl-11-hbenzo [b]fluorene derivatives and analogs for medicinal use
02/28/2002CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
02/27/2002EP1182199A1 Process for preparing amic acid esters
02/27/2002EP1181283A1 Diaminothiazoles and their use for inhibiting protein kinases
02/27/2002EP1181267A1 Halogen compounds
02/27/2002EP0971907B1 Method for producing 1,3-di-substituted 2-nitroguanidines
02/27/2002CN1337955A Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
02/27/2002CN1337941A Amide derivatives
02/27/2002CN1337932A Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treamtent of respiratory diseases
02/27/2002CN1079792C 酶抑制剂 Inhibitors
02/26/2002US6350892 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
02/26/2002US6350878 Intermediates for the synthesis of epothilones and methods for their preparation
02/26/2002US6350767 Growth hormone release stimulant
02/26/2002CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present
02/26/2002CA2128119C Benzospiroalkene derivatives, process for their preparation and pharmaceutical compositions containing them
02/21/2002WO2002014312A1 Tetrazolyl-phenyl acetamide glucokinase activators
02/21/2002WO2002014294A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
02/21/2002WO2002014291A1 PPARδ ACTIVATORS
02/21/2002WO2002014275A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
02/21/2002WO2002014261A2 4-substituted d-glutamic acid derivatives for use as antibiotic
02/21/2002WO2002014259A1 Calcium receptor antagonists
02/21/2002WO2002013611A1 2-phenyliminothiazolines, their preparation method and anti-rice blast agent containing the same
02/21/2002WO2001081328A3 Thiazolidinedione analogues and their use for the treatment of diabetes
02/21/2002WO2000054729A8 Heterocyclic aromatic compounds useful as growth hormone secretagogues
02/21/2002US20020022631 Use of 2-aminothiazoline derivatives as inhibitors of inducible no-synthase
02/21/2002US20020022622 Administering effective amount of oxalzole, thiazole or imidazole derivatives to cure diseases associated with protein aging
02/21/2002DE10039998A1 Neue substituierte Diareno-azepin-Derivate als Integrin Liganden New substituted Diareno-azepine derivatives as integrin ligands
02/21/2002DE10039265A1 New 2-acylamino-5-aminosulfonyl-1,3-thiazole derivatives, useful as antiviral agents, especially for treatment or prophylaxis of herpes simplex virus infections
02/20/2002EP1180519A1 Hydrochloride of fused-heterocycle compound
02/20/2002EP1180512A1 Fungicidal phenylimine derivatives
02/20/2002EP1180098A1 New compounds
02/20/2002CN1336930A Bridged heterocyclic derivatives
02/20/2002CN1336921A Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4